GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (FRA:DTC) » Definitions » FCF Yield %

Defence Therapeutics (FRA:DTC) FCF Yield % : -8.50 (As of May. 26, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Defence Therapeutics's Trailing 12-Month Free Cash Flow is €-3.18 Mil, and Market Cap is €36.72 Mil. Therefore, Defence Therapeutics's FCF Yield % for today is -8.50%.

The historical rank and industry rank for Defence Therapeutics's FCF Yield % or its related term are showing as below:

FRA:DTC' s FCF Yield % Range Over the Past 10 Years
Min: -8.54   Med: 0   Max: 0
Current: -8.5


FRA:DTC's FCF Yield % is ranked better than
61.11% of 1553 companies
in the Biotechnology industry
Industry Median: -14.53 vs FRA:DTC: -8.50

Defence Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.


Defence Therapeutics FCF Yield % Historical Data

The historical data trend for Defence Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Defence Therapeutics FCF Yield % Chart

Defence Therapeutics Annual Data
Trend Jun20 Jun21 Jun22
FCF Yield %
- -0.97 -8.15

Defence Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.69 -8.77 -4.85 -5.06 -5.49

Competitive Comparison of Defence Therapeutics's FCF Yield %

For the Biotechnology subindustry, Defence Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Defence Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Defence Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Defence Therapeutics's FCF Yield % falls into.



Defence Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Defence Therapeutics's FCF Yield % for the fiscal year that ended in Jun. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-4.465 / 54.766634
=-8.15%

Defence Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.953 * 4 / 69.372732
=-5.49%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Defence Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Defence Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Defence Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Defence Therapeutics (FRA:DTC) Business Description

Traded in Other Exchanges
Address
200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6
Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.